ENG

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals

News

Bird & Bird's international Competition Group strengthens position through non-governmental advisor roles to competition and consumer authorities

Dec 18 2024

Read More

Deal

Bird & Bird advises Planet A Foods on $30 million financing round

Dec 18 2024

Read More

News

Bird & Bird appoints finance expert Caroline Bruyant Bonde as new partner in Copenhagen

Dec 16 2024

Read More

Deal

Bird & Bird advises the GMP Group on its acquisition of the Reedijk Wheels and Tyres Group

Dec 13 2024

Read More

Deal

Bird & Bird advises Konecranes on the acquisition of Peinemann Container Handling and Peinemann Port Services

Dec 13 2024

Read More

Deal

Bird & Bird advises Hitachi Energy on major industrial real estate project

Dec 13 2024

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare